Cmas | cytidine monophospho-N-acetylneuraminic acid synthetase
Physiological systems
20 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Behavior/neurological Mortality/aging
18 No significant impact
4 Not tested
Data collections
Gene metrics:3Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
preweaning lethality, complete penetrance | 1 supporting dataset | Cmasem1(IMPC)Hmgu | homozygote | Early adult | N/A * | ||
abnormal gait | 1 supporting dataset | Cmasem1(IMPC)Hmgu | heterozygote | Early adult | 3.4x10-5 |
| | | | | | | | | |
External links
No external links available for Cmas.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Cmasem1(IMPC)Hmgu | Exon Deletion | | mouse |
Cmastm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector es cell |
Cmastm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | es cell |